Meeting
2024 ASCO Annual Meeting
Polyploid circulating stromal cells in blood to identify invasive solid tumors and to prognosticate for highly aggressive cancer subtypes.
Authors
Daniel L Adams
Creatv MicroTech, Inc., Monmouth Junction, NJ
Daniel L Adams , Steven H. Lin , Harvey I. Pass , Martin Joseph Edelman , Toshiaki Iwase , Naoto Tada Ueno , Raymond C. Bergan , Susan Tsai , Mohammed Aldakkak , Rebecca Aft , Mark Watson , Amy K. Kim , Kazuaki Chikamatsu , Masanori Hayashi , David Loeb , Navin Pinto , Thai Huu Ho , Sandra M. Gaston , Sanoj Punnen , Jeffrey R Marks
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 3053)
DOI
10.1200/JCO.2024.42.16_suppl.3053
Abstract #
3053
Poster Bd #
198
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical presentation and delay to diagnosis and treatment in Mexican patients with gastric cancer.
First Author: Jorge Humberto Hernandez-Felix
Poster
2022 ASCO Annual Meeting
Characterization of time to diagnosis indicates shorter interval for screenable versus symptom-driven cancers.
First Author: Vladimir Gainullin
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Incomplete preoperative staging results in suboptimal treatment in rectal cancer patients: A population-based study.
First Author: Sunil Patel
Poster
2021 ASCO Annual Meeting
Interim results of PATHFINDER, a clinical use study using a methylation-based multi-cancer early detection test.
First Author: Tomasz M. Beer